Inflammatory Response: Clinical Trials

7 trials for Inflammatory Response, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 11Completed 1

Follow Inflammatory Response: new trials by email Literature Review of Inflammatory Response trials Research Report on Inflammatory Response

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
Methylprednisolone, Isotonic saline - ST Elevation Myocardial Infarction, Inflammatory Response
Phase 2CompletedThomas Engstrom5302022-11-142026-03-27
An Inflammatory Challenge Using Endotoxin
Placebo, Endotoxin - Alcohol Use Disorder, Inflammatory Response
Phase 2CompletedUniversity of California, Los Angeles202021-10-192025-05-01
Asses the Anti-inflammatory Effects of Short Term Copaxone Therapy on Patients the Acute Decompensated Heart Failure
Copaxone, guideline directed medical therapy (GDMT) - Acute Decompensated Heart Failure, Cytokine Storm
Phase 2CompletedHadassah Medical Organization142021-01-042023-08-22
An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19
Icosapent ethyl - COVID-19, Inflammatory Response
Phase 2CompletedCanadian Medical and Surgical Knowledge Translation Research Group1002020-06-042021-12-22
Effects of Metformin in a Non-Diabetic Patient Population
MetFORMIN Hydrochloride ER, Placebo - Inflammatory Response
Phase 1 / Phase 2CompletedBrian Zuckerbraun322019-01-222023-01-11
Tramadol Versus Lidocaine Infiltration for Tonsillectomy
peritonsillar infiltration - Peri-tonsillar Analgesic Infiltration, Tonsillectomy
Phase 2CompletedImam Abdulrahman Bin Faisal University902011-12-012014-03-18
Immune Effects of Vitamin D in Hemodialysis Patients
paricalcitol - End Stage Renal Disease, Hemodialysis
Phase 2CompletedRenal Research Institute202004-12-012009-05-13

Narrower conditions

Alcoholism (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Consciousness Disorders (1)  ·  Cytokine Release Syndrome (1)  ·  Fractures, Stress (1)  ·  Heart Failure (1)  ·  Inflammation (1)  ·  Kidney Failure, Chronic (1)  ·  Myocardial Reperfusion Injury (1)  ·  Pain, Postoperative (1)  ·  Reperfusion Injury (1)  ·  ST Elevation Myocardial Infarction (1)  ·  Thrombosis (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (5)  ·  Pathologic Processes (4)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (2)  ·  Neurologic Manifestations (2)  ·  Postoperative Complications (2)  ·  Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Alcohol-Related Disorders (1)  ·  Cardiomyopathies (1)  ·  Chemically-Induced Disorders (1)  ·  Chronic Disease (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Disease Attributes (1)

Interventions

Sodium Chloride (2)  ·  Endotoxins (1)  ·  Glatiramer Acetate (1)  ·  Metformin (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  eicosapentaenoic acid ethyl ester (1)  ·  paricalcitol (1)

Sponsors

Brian Zuckerbraun (1)  ·  Canadian Medical and Surgical Knowledge Translation Research Group (1)  ·  Hadassah Medical Organization (1)  ·  Imam Abdulrahman Bin Faisal University (1)  ·  Renal Research Institute (1)  ·  Thomas Engstrom (1)  ·  University of California, Los Angeles (1)

Countries

United States (3)  ·  Canada (1)  ·  Denmark (1)  ·  Israel (1)  ·  Saudi Arabia (1)

Top investigators

Abdulhadi Al'Saflan, MD (1)  ·  Alaa M. Khidr, MD (1)  ·  Brian Zuckerbraun, MD (1)  ·  Hany A. Mowafi, MD (1)  ·  Jasmine M Madsen, MD (1)  ·  Lara Ray, PhD (1)  ·  Nathan W Levin, MD (1)  ·  Offer Amir, PhD (1)  ·  Subodh Verma, MD, PhD (1)

Results publications

PMID 34462732, PMID 39211964, PMID 40102868